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After successful PTA of a femoral artery obstruction, compliant Fogarty balloon catheters. In this type of 
the reported patency at 6 months vanes from 23% to arterial injury there is only minimal damage to the 
75%. 1'2 The pathophyslology of restenosls after PTA medial layer of the artery. 
revolves intimal hyperplasia t the site of injury, recoil Intlmal (or neointimal) hyperplasma h s been defined 
and remodelling. 3 The vascular wall is by no means as the abnormal migration and proliferation of vascular 
static; the different components of the vascular wall, smooth muscle cells with an associated abundant de- 
cells and extracellular matrix, dynamically increase, position of extracellular connective tissue matrix. 9So 
decrease and/or reorganise in response to physio- far, neointimal hyperplasia following angioplasty has 
logical and pathological stimuli. Endothelial cells, vas- been shown to be refractory to all pharmacological 
cular smooth muscle cells and adventitial fibroblasts therapies, ° Intravascular stents seem to counteract 
from the vessel wall and blood borne cells and sub- early recoil of balloon-dilated vessels and reduce the 
stances play an intricate role in the process of con- constricting effect of vascular emodelling, but they 
tinuous maintenance of the integrity and function of may enhance the problem of neomtimal hyperplasia. 
the vascular wal lY  The process of geometric re- Since proliferation of vascular smooth muscle cells 
modelling of arteries consists of a change of the total plays the main role in neointimal hyperplasia, there 
arterial circumference. The forces that determine 
shrinking or enlargement are mostly unknown. 3Recent is need for an effective antiproliferative agent. Over 
the years ionising radiation has demonstrated anti- 
findings suggest that adventitial fibroblasts could play proliferative properties in malignant as well as benign 
an important role in this process of vascular re- 
modelling. 6 The presence of rapidly proliferating proliferative disorders. For example, radiotherapy has 
hbroblasts in the adventitia surrounding the stretched successfully been used for several decades in reducing 
and partially disrupted segment of media after balloon the post-surgical recurrence of pterygia and keloids, 
dilatation and the up-regulation of contractile proteins in the prevention of heterotopic ossification as well as 
in the treatment of macular degeneration, pituitary in these cells, (redesignated asmyofibroblasts), appear 
to play a very important role in the process of vascular gland adenomas, A-V malformations and men- 
remodelling by constricting the vessels from the ad- ingiomas. ~1-14 Similarly, in animal and human ex- 
ventitial side, thereby contributing to postangloplasty periments both external beam and endovascular 
restenosis.S radiation have been shown to reduce, in a dose de- 
More knowledge has been accumulated on the pro- pendent fashion, arterial smooth muscle cell pro- 
cess of post-injury neomtimal hyperplasia. In animal liferation and thereby the incidence and severity of 
experiments his process has been extensively studied restenosis after PTA 15-17 Endovascular irradiation 
using the model of endothehal denudation of peri- seems most promising, especially for the more deeply 
pheral arteries by removing the endothelial cells with situated vessels. 
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Endovascular radiation can be delivered by means likely. The first results of this trial are to be expected 
of catheter-based systems and by radioactive stents, in the year 2001. 
The effective and safe dose of endovascular ra&ation 
in case of the single dose catheter-based application 
appears to be between 14 and 25 Gy. 18 Recently the 
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